Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.
Jane O'Halloran,Eyal Kedar,Kevin J Anstrom,Matthew W McCarthy,Emily R Ko, Patricia Segura Nunez,Cynthia Boucher,P Brian Smith, Reynold A Panettieri,Sabina Mendivil Tuchia de Tai,Martin Maillo,Akram Khan,Alfredo J Mena Lora,Matthias Salathe, Gerardo Capo,Daniel Rodriguez Gonzalez,Thomas F Patterson,Christopher Palma,Horacio Ariza,Maria Patelli Lima,Anne M Lachiewicz,John Blamoun,Esteban Nannini,Eduardo Sprinz,Analia Mykietiuk,Radica Alicic,Adriana M Rauseo,Cameron R Wolfe,Britta Wittig,Daniel K Benjamin,Steven E McNulty,Pearl Zakroysky,Susan Halabi, Sandra Butler,Jane Atkinson,Stacey J Adam, Richard Melsheimer,Soju Chang,Lisa LaVange,Michael Proschan,Samuel A Bozzette,William G Powderly medRxiv : the preprint server for health sciences（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper